Regeneron Pharmaceuticals
Utility Patents
Last updated:
List of all Regeneron Pharmaceuticals patents 248 in total
| Status | Patent |
|---|---|
Grant | Utility: Mouse having an engineered immunoglobulin lambda light chain Filling date: 12 Sep 2025 Issue date: 6 Jul 2021 |
Grant | Utility: Methods for treating active eosinophilic esophagitis Filling date: 12 Sep 2025 Issue date: 6 Jul 2021 |
Grant | Utility: Methods for de novo protein sequencing Filling date: 12 Sep 2025 Issue date: 29 Jun 2021 |
Grant | Utility: Genetically modified non-human animals and methods of use thereof Filling date: 12 Sep 2025 Issue date: 8 Jun 2021 |
Grant | Utility: Mice expressing a limited immunoglobulin light chain repertoire Filling date: 12 Sep 2025 Issue date: 8 Jun 2021 |
Grant | Utility: Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein Filling date: 12 Sep 2025 Issue date: 8 Jun 2021 |
Grant | Utility: Non-human animals having a humanized signal-regulatory protein gene Filling date: 12 Sep 2025 Issue date: 1 Jun 2021 |
Grant | Utility: Humanized low affinity FC.gamma.R mouse cells Filling date: 12 Sep 2025 Issue date: 1 Jun 2021 |
Grant | Utility: Methods and compositions for assessing CRISPER/Cas-mediated disruption or excision and CRISPR/Cas-induced recombination with an exogenous donor nucleic acid in vivo Filling date: 12 Sep 2025 Issue date: 1 Jun 2021 |
Grant | Utility: Methods for quantitating individual antibodies from a mixture Filling date: 12 Sep 2025 Issue date: 1 Jun 2021 |
Grant | Utility: Humanized dipeptidyl-peptidase IV (DPP4) animals Filling date: 12 Sep 2025 Issue date: 25 May 2021 |
Grant | Utility: Non-human animals having a humanized B-cell activating factor gene Filling date: 12 Sep 2025 Issue date: 11 May 2021 |
Grant | Utility: Methods for inhibiting atherosclerosis by administering an anti-PCSK9 antibody Filling date: 12 Sep 2025 Issue date: 4 May 2021 |
Grant | Utility: Methods of treating severe insulin resistance by interfering with glucagon receptor signaling Filling date: 12 Sep 2025 Issue date: 4 May 2021 |
Grant | Utility: Genetically modified major histocompatibility complex mice Filling date: 12 Sep 2025 Issue date: 27 Apr 2021 |
Grant | Utility: Common light chain mouse Filling date: 12 Sep 2025 Issue date: 27 Apr 2021 |
Grant | Utility: Antibodies comprising chimeric constant domains Filling date: 12 Sep 2025 Issue date: 27 Apr 2021 |
Grant | Utility: Methods of modifying genes in eukaryotic cells Filling date: 12 Sep 2025 Issue date: 27 Apr 2021 |
Grant | Utility: Assembly line with integrated electronic visual inspection Filling date: 12 Sep 2025 Issue date: 27 Apr 2021 |
Grant | Utility: Non-human animals expressing exogenous terminal deoxynucleotidyltransferase Filling date: 12 Sep 2025 Issue date: 20 Apr 2021 |
Grant | Utility: Anti-SARS-CoV-2-Spike glycoprotein antibodies and antigen-binding fragments Filling date: 12 Sep 2025 Issue date: 13 Apr 2021 |
Grant | Utility: Targeted modification of rat genome Filling date: 12 Sep 2025 Issue date: 13 Apr 2021 |
Grant | Utility: Use of a VEGF antagonist to treat angiogenic eye disorders Filling date: 12 Sep 2025 Issue date: 13 Apr 2021 |
Grant | Utility: Methods of assessing antibody-drug conjugates Filling date: 12 Sep 2025 Issue date: 13 Apr 2021 |
Grant | Utility: Compositions comprising IL6R antibodies for the treatment of uveitis and macular edema and methods of using same Filling date: 12 Sep 2025 Issue date: 6 Apr 2021 |
Grant | Utility: Cell culture medium for eukaryotic cells Filling date: 12 Sep 2025 Issue date: 30 Mar 2021 |
Grant | Utility: Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation Filling date: 12 Sep 2025 Issue date: 30 Mar 2021 |
Grant | Utility: Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments Filling date: 12 Sep 2025 Issue date: 23 Mar 2021 |
Grant | Utility: Method for generating a humanized transgenic mouse comprising a human APRIL gene Filling date: 12 Sep 2025 Issue date: 23 Mar 2021 |
Grant | Utility: Mice that make V.sub.L binding proteins Filling date: 12 Sep 2025 Issue date: 23 Mar 2021 |
Grant | Utility: Human antibodies to GFR.alpha.3 and methods of making thereof Filling date: 12 Sep 2025 Issue date: 16 Mar 2021 |
Grant | Utility: Fusion protein comprising apelin and an anti-APLNR antibody Filling date: 12 Sep 2025 Issue date: 16 Mar 2021 |
Grant | Utility: Human antibodies to S. aureus hemolysin A toxin Filling date: 12 Sep 2025 Issue date: 9 Mar 2021 |
Grant | Utility: Anti-TMPRSS2 antibodies and antigen-binding fragments Filling date: 12 Sep 2025 Issue date: 9 Mar 2021 |
Grant | Utility: Anti-PCSK9 antibodies Filling date: 12 Sep 2025 Issue date: 9 Mar 2021 |
Grant | Utility: Method of using mouse having a humanized cluster of differentiation 47 gene Filling date: 12 Sep 2025 Issue date: 9 Mar 2021 |
Grant | Utility: Anti-MUC16 antibodies Filling date: 12 Sep 2025 Issue date: 9 Mar 2021 |
Grant | Utility: Non-human animals expressing humanized CD3 complex Filling date: 12 Sep 2025 Issue date: 2 Mar 2021 |
Grant | Utility: Methods for increasing lean body mass with resistance training and a GDF8 inhibitor that is an anti-GDF8 antibody Filling date: 12 Sep 2025 Issue date: 2 Mar 2021 |
Grant | Utility: Diagnostic tests and methods for assessing safety, efficacy or outcome of allergen-specific immunotherapy (SIT) Filling date: 12 Sep 2025 Issue date: 2 Mar 2021 |
Grant | Utility: Taurine supplemented cell culture medium and methods of use Filling date: 12 Sep 2025 Issue date: 23 Feb 2021 |
Grant | Utility: Compositions and methods for reducing bioburden in chromatography Filling date: 12 Sep 2025 Issue date: 23 Feb 2021 |
Grant | Utility: Methods of treating PRLR positive breast cancer Filling date: 12 Sep 2025 Issue date: 23 Feb 2021 |
Grant | Utility: Compositions for the treatment of rheumatoid arthritis and methods of using same Filling date: 12 Sep 2025 Issue date: 23 Feb 2021 |
Grant | Utility: Sterilisation method Filling date: 12 Sep 2025 Issue date: 16 Feb 2021 |
Grant | Utility: Sterilisation method Filling date: 12 Sep 2025 Issue date: 2 Feb 2021 |
Grant | Utility: Dual-column LC-MS system and methods of use thereof Filling date: 12 Sep 2025 Issue date: 2 Feb 2021 |
Grant | Utility: ADAM6 mice Filling date: 12 Sep 2025 Issue date: 2 Feb 2021 |
Grant | Utility: ADAM6 mice Filling date: 12 Sep 2025 Issue date: 2 Feb 2021 |
Grant | Utility: Radiolabeled anti-LAG3 antibodies for immuno-PET imaging Filling date: 12 Sep 2025 Issue date: 2 Feb 2021 |
Showing 50 to 100 of 248 patents.